Federal investment in RNA vaccine research has supported nearly three decades of scientific work spanning infectious diseases, cancer, and vaccine development, but recent and proposed funding cuts ...

Under the settlement, Genevant Sciences and Arbutus Biopharma will grant Moderna a non-exclusive license to their lipid nanoparticle technology for mRNA delivery in infectious disease vaccines. If ...

COVID-19 RNA may induce monocytes to develop cancer-fighting properties, potentially shrinking tumors in certain metastatic cancers. Patients resistant to prior immunotherapy showed the most benefit ...

Co-infection of influenza virus and SARS-CoV-2 can lead to more severe disease than infection of either alone.

Scientists have discovered a surprising silver lining of COVID-19 infection. A new study by researchers at Northwestern Medicine Canning Thoracic Institute, published in the Journal of Clinical ...

The COVID-19 virus may have the surprising ability to shrink some tumors, paving the way for new cancer treatments, a new study has found. The research, conducted at the Northwestern Medicine Canning ...

The European Medicines Agency (EMA) announced Friday it has recommended Moderna’s combined mRNA COVID-19 and flu vaccine be ...

Hot spots within the ED included the acute-care area (9 of 13 samples positive), the public waiting room (6 of 12), and a walkway area (1 of 1). In the ICU, positive samples were detected in a staff ...

Add Yahoo as a preferred source to see more of our stories on Google. Scientists have discovered a surprising silver lining of COVID-19 infection. A new study by researchers at Northwestern Medicine ...